vs
FLOTEK INDUSTRIES INC（FTK）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是FLOTEK INDUSTRIES INC的1.0倍（$69.8M vs $67.5M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 4.5%，领先379.6%），FLOTEK INDUSTRIES INC同比增速更快（33.0% vs 21.2%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 29.3%）
Flotek Industries是一家技术驱动的多元化企业，主要开发和供应特种化学品、高性能材料及相关设备解决方案，服务全球能源、采矿和工业制造领域，助力客户提升运营效率。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
FTK vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.0倍
$67.5M
营收增速更快
FTK
高出11.8%
21.2%
净利率更高
RIGL
高出379.6%
4.5%
两年增速更快
RIGL
近两年复合增速
29.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $67.5M | $69.8M |
| 净利润 | $3.0M | $268.1M |
| 毛利率 | 22.5% | 91.5% |
| 营业利润率 | 8.9% | 33.2% |
| 净利率 | 4.5% | 384.0% |
| 营收同比 | 33.0% | 21.2% |
| 净利润同比 | -31.7% | 1769.2% |
| 每股收益（稀释后） | $0.09 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FTKRIGL
| Q4 25 | $67.5M | $69.8M | ||
| Q3 25 | $56.0M | $69.5M | ||
| Q2 25 | $58.4M | $101.7M | ||
| Q1 25 | $55.4M | $53.3M | ||
| Q4 24 | $50.8M | $57.6M | ||
| Q3 24 | $49.7M | $55.3M | ||
| Q2 24 | $46.2M | $36.8M | ||
| Q1 24 | $40.4M | $29.5M |
净利润FTKRIGL
| Q4 25 | $3.0M | $268.1M | ||
| Q3 25 | $20.4M | $27.9M | ||
| Q2 25 | $1.8M | $59.6M | ||
| Q1 25 | $5.4M | $11.4M | ||
| Q4 24 | $4.4M | $14.3M | ||
| Q3 24 | $2.5M | $12.4M | ||
| Q2 24 | $2.0M | $-1.0M | ||
| Q1 24 | $1.6M | $-8.2M |
毛利率FTKRIGL
| Q4 25 | 22.5% | 91.5% | ||
| Q3 25 | 31.7% | 93.2% | ||
| Q2 25 | 24.7% | 95.6% | ||
| Q1 25 | 22.5% | 91.7% | ||
| Q4 24 | 24.2% | 89.9% | ||
| Q3 24 | 18.3% | 85.5% | ||
| Q2 24 | 19.9% | 92.4% | ||
| Q1 24 | 21.8% | 93.1% |
营业利润率FTKRIGL
| Q4 25 | 8.9% | 33.2% | ||
| Q3 25 | 16.2% | 40.9% | ||
| Q2 25 | 4.4% | 60.1% | ||
| Q1 25 | 10.1% | 23.9% | ||
| Q4 24 | 10.1% | 28.9% | ||
| Q3 24 | 5.5% | 25.4% | ||
| Q2 24 | 4.8% | 1.2% | ||
| Q1 24 | 5.2% | -23.6% |
净利率FTKRIGL
| Q4 25 | 4.5% | 384.0% | ||
| Q3 25 | 36.3% | 40.2% | ||
| Q2 25 | 3.0% | 58.6% | ||
| Q1 25 | 9.7% | 21.5% | ||
| Q4 24 | 8.7% | 24.9% | ||
| Q3 24 | 5.1% | 22.5% | ||
| Q2 24 | 4.3% | -2.8% | ||
| Q1 24 | 3.9% | -27.9% |
每股收益（稀释后）FTKRIGL
| Q4 25 | $0.09 | $14.11 | ||
| Q3 25 | $0.53 | $1.46 | ||
| Q2 25 | $0.05 | $3.28 | ||
| Q1 25 | $0.17 | $0.63 | ||
| Q4 24 | $0.15 | $0.82 | ||
| Q3 24 | $0.08 | $0.70 | ||
| Q2 24 | $0.06 | $-0.06 | ||
| Q1 24 | $0.05 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $5.7M | $155.0M |
| 总债务越低越好 | $40.0M | $52.5M |
| 股东权益账面价值 | $113.1M | $391.5M |
| 总资产 | $220.0M | $513.6M |
| 负债/权益比越低杠杆越低 | 0.35× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资FTKRIGL
| Q4 25 | $5.7M | $155.0M | ||
| Q3 25 | $4.6M | $137.1M | ||
| Q2 25 | $5.0M | $108.4M | ||
| Q1 25 | $6.3M | $77.1M | ||
| Q4 24 | $4.4M | $77.3M | ||
| Q3 24 | $5.0M | $61.1M | ||
| Q2 24 | $4.8M | $49.1M | ||
| Q1 24 | $5.2M | $49.5M |
总债务FTKRIGL
| Q4 25 | $40.0M | $52.5M | ||
| Q3 25 | $40.0M | $60.0M | ||
| Q2 25 | $40.0M | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | $194.0K | $60.0M |
股东权益FTKRIGL
| Q4 25 | $113.1M | $391.5M | ||
| Q3 25 | $110.5M | $117.6M | ||
| Q2 25 | $71.8M | $81.9M | ||
| Q1 25 | $119.7M | $18.6M | ||
| Q4 24 | $113.9M | $3.3M | ||
| Q3 24 | $109.0M | $-14.6M | ||
| Q2 24 | $106.2M | $-29.9M | ||
| Q1 24 | $103.9M | $-31.7M |
总资产FTKRIGL
| Q4 25 | $220.0M | $513.6M | ||
| Q3 25 | $212.7M | $242.5M | ||
| Q2 25 | $172.2M | $206.7M | ||
| Q1 25 | $170.2M | $176.0M | ||
| Q4 24 | $170.8M | $164.0M | ||
| Q3 24 | $160.6M | $139.4M | ||
| Q2 24 | $156.0M | $128.4M | ||
| Q1 24 | $155.8M | $126.5M |
负债/权益比FTKRIGL
| Q4 25 | 0.35× | 0.13× | ||
| Q3 25 | 0.36× | 0.51× | ||
| Q2 25 | 0.56× | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $6.2M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 2.07× | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流FTKRIGL
| Q4 25 | $6.2M | $22.0M | ||
| Q3 25 | $-1.9M | $24.0M | ||
| Q2 25 | $-4.5M | $30.5M | ||
| Q1 25 | $7.3M | $-893.0K | ||
| Q4 24 | $-2.6M | $14.5M | ||
| Q3 24 | $5.1M | $21.7M | ||
| Q2 24 | $-3.1M | $302.0K | ||
| Q1 24 | $3.9M | $-5.0M |
现金转化率FTKRIGL
| Q4 25 | 2.07× | 0.08× | ||
| Q3 25 | -0.09× | 0.86× | ||
| Q2 25 | -2.54× | 0.51× | ||
| Q1 25 | 1.36× | -0.08× | ||
| Q4 24 | -0.58× | 1.01× | ||
| Q3 24 | 2.01× | 1.75× | ||
| Q2 24 | -1.55× | — | ||
| Q1 24 | 2.49× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FTK
| Related Party | $49.6M | 74% |
| Nonrelated Party | $17.9M | 26% |
RIGL
暂无分部数据
